Market capitalization | $205.84m |
Enterprise Value | $61.43m |
P/E (TTM) P/E ratio | 7.02 |
EV/FCF (TTM) EV/FCF | 1.13 |
EV/Sales (TTM) EV/Sales | 0.08 |
P/S ratio (TTM) P/S ratio | 0.27 |
P/B ratio (TTM) P/B ratio | 1.00 |
Dividend yield | 34.86% |
Last dividend (FY22) | $6.56 |
As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.
2 Analysts have issued a Medifast Inc forecast:
2 Analysts have issued a Medifast Inc forecast:
Jun '24 |
+/-
%
|
||
Net Profit | -8.15 -8.15 |
127%
127%
|
|
Depreciation and Amortization | 3.07 3.07 |
32%
32%
|
|
Stock Compensation | 2.45 2.45 |
2%
2%
|
|
Operating Cash Flow | 13 13 |
70%
70%
|
|
Investments | 1.94 1.94 |
11%
11%
|
|
Dividend Paid | - - |
-
|
|
Free Cash Flow | 11 11 |
73%
73%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Medifast, Inc. is a health and wellness company, which engages in the manufacture and distribution of healthy living products and programs. Its platform includes OPTAVIA, which offers its costumers lifelong transformation, one healthy habit at a time. The company was founded by William Vitale in 1980 and is headquartered in Baltimore, MD
Head office | United States |
CEO | Daniel Chard |
Employees | 634 |
Founded | 1981 |
Website | www.medifastinc.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.